| P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer S Shariat, A Badiee, SA Jalali, M Mansourian, M Yazdani, SA Mortazavi, ... Cancer letters 355 (1), 54-60, 2014 | 73 | 2014 |
| Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN M Mansourian, A Badiee, SA Jalali, S Shariat, M Yazdani, M Amin, ... Immunology letters 162 (1), 87-93, 2014 | 68 | 2014 |
| P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer N Farzad, N Barati, AA Momtazi-Borojeni, M Yazdani, A Arab, A Razazan, ... Artificial cells, nanomedicine, and biotechnology 47 (1), 664-672, 2019 | 30 | 2019 |
| Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy M Yazdani, Z Gholizadeh, AR Nikpoor, N Mohamadian Roshan, ... Scientific Reports 11 (1), 14661, 2021 | 19 | 2021 |
| Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma M Yazdani, Z Gholizadeh, AR Nikpoor, M Hatamipour, B Alani, H Nikzad, ... Vaccine 38 (35), 5665-5677, 2020 | 18 | 2020 |
| Preparation of nanoliposomes linked to HER2/neu‐derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer S Rastakhiz, M Yazdani, S Shariat, A Arab, AA Momtazi‐Borojeni, ... Journal of Cellular Biochemistry 120 (2), 1294-1303, 2019 | 18 | 2019 |
| Stimulation of tumor-specific immunity by p5 HER-2/neu generated peptide encapsulated in nano-liposomes with high phase transition temperature phospholipids M Yazdani, S Amir Jalali, A Badiee, S Shariat, M Mansourian, L Arabi, ... Current drug delivery 14 (4), 492-502, 2017 | 15 | 2017 |
| Ex vivo-generated dendritic cell-based vaccines in melanoma: the role of nanoparticulate delivery systems M Yazdani, MR Jaafari, J Verdi, B Alani, M Noureddini, A Badiee Immunotherapy 12 (5), 333-349, 2020 | 14 | 2020 |
| Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy M Yazdani, M Hatamipour, B Alani, H Nikzad, NM Roshan, J Verdi, ... Iranian Journal of Basic Medical Sciences 23 (8), 1065, 2020 | 13 | 2020 |
| Preparation of nanoliposomes containing HER2/neu (P5+ 435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer L Naghibi, M Yazdani, AA Momtazi-Borojeni, A Razazan, S Shariat, ... PLoS One 15 (12), e0243550, 2020 | 12 | 2020 |
| Liposomal celecoxib combined with dendritic cell therapy enhances antitumor efficacy in melanoma V Jahani, M Yazdani, A Badiee, MR Jaafari, L Arabi Journal of Controlled Release 354, 453-464, 2023 | 6 | 2023 |
| Comparison of two routes of administration of a cationic liposome formulation for a prophylactic DC vaccination in a murine melanoma model M Yazdani, AR Nikpoor, Z Gholizadeh, NM Roshan, A Seifalian, ... International Immunopharmacology 98, 107833, 2021 | 5 | 2021 |
| Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine S Tahaghoghi-Hajghorbani, M Yazdani, AR Nikpoor, M Hatamipour, ... Scientific Reports 13 (1), 5802, 2023 | 3 | 2023 |
| Characterization of T/B cell antigen specific-engineered tumors for studying T cell and GC B cell function in a murine model of NSCLC AJ Ruiz-Justiz, M Yazdani, X Sun, L Chen, M Wang, J Le, H Guo, C Cui, ... | | 2022 |
| Chemo-Immunotherapy by Nanoliposomal Epacadostat and Docetaxel Combination to Ido1 Inhibition and Tumor Microenvironment Suppression R Khoshkhabar, M Yazdani, SH Alavizadeha, Z Saberi, L Arabi, ... Available at SSRN 4788489, 0 | | |
Mahmoud Reza JaafariProf. of Pharmaceutics and Pharmaceutical NanotechnologyVerified email at mums.ac.ir
